AIA
GSK icon

Arcadia Investment Advisors’s GSK GSK Stock Holding History

Arcadia Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$21.8K – 100
2022
Q2 		$21.8K Hold
400
– – 0.02% 63
2022
Q1 		$21.8K Hold
400
– – 0.01% 66
2021
Q4 		$22.1K Hold
400
– – 0.01% 65
2021
Q3 		$19.1K Hold
400
– – 0.01% 67
2021
Q2 		$19.9K Hold
400
– – 0.01% 64
2021
Q1 		$17.8K Hold
400
– – 0.01% 61
2020
Q4 		$18.4K Hold
400
– – 0.01% 62
2020
Q3 		$18.8K Buy
+400
New +$20K 0.01% 59

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arcadia Investment Advisors's GSK Position: Q3 2022 in Review

Arcadia Investment Advisors sold out of GSK (GSK) in Q3 2022, closing a stake of 400 shares — an estimated $21.8K sold.

Arcadia Investment Advisors first reported a position in GSK in Q3 2020 and held it in 8 quarters. The position peaked at $22.1K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Arcadia Investment Advisors reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Arcadia Investment Advisors sold 400 GSK shares in Q3 2022, an estimated $21.8K.
  • Arcadia Investment Advisors first reported a position in GSK in Q3 2020 and held it in 8 quarters.
  • Arcadia Investment Advisors's GSK position peaked at $22.1K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Arcadia Investment Advisors's 13F filing for Q3 2022, filed 19 Dec 2024.